{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:21:33Z","timestamp":1767846093464,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.vaccine.2016.11.046","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T19:15:47Z","timestamp":1480792547000},"page":"337-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model"],"prefix":"10.1016","volume":"35","author":[{"given":"Qingfu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Pryharski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Pichichero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.046_b0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1590\/S0036-36342001000400012","article-title":"Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines","volume":"43","author":"Echaniz-Aviles","year":"2001","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.vaccine.2016.11.046_b0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/21645515.2015.1052198","article-title":"Next generation protein based Streptococcus pneumoniae vaccines","volume":"12","author":"Pichichero","year":"2016","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2016.11.046_b0015","article-title":"Current status and perspectives on protein-based pneumococcal vaccines","volume":"1\u201311","author":"Darrieux","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jinf.2014.06.006","article-title":"Review: current and new generation pneumococcal vaccines","volume":"69","author":"Feldman","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.11.046_b0025","unstructured":"WHO. Pneumococcal vaccines-WHO (World Healthy Orginization) position paper \u2013 2012. In: WHO, editor. 6 April 2012, 87th year\/6 avril 2012, 87e ann\u00e9e, No 14, 2012, 87, 129\u2013144. Geneva, Switzerland 2012."},{"key":"10.1016\/j.vaccine.2016.11.046_b0030","first-page":"15","article-title":"Update on otitis media \u2013 prevention and treatment","volume":"7","author":"Qureishi","year":"2014","journal-title":"Infect Drug Resistance"},{"key":"10.1016\/j.vaccine.2016.11.046_b0035","doi-asserted-by":"crossref","first-page":"e36226","DOI":"10.1371\/journal.pone.0036226","article-title":"Burden of disease caused by otitis media: systematic review and global estimates","volume":"7","author":"Monasta","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.046_b0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/0009922814533592","article-title":"Payment analysis of two diagnosis and management approaches of acute otitis media","volume":"53","author":"Casey","year":"2014","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.vaccine.2016.11.046_b0045","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0000000000001216","article-title":"Ten-Year Study of Acute Otitis Media in Rochester, NY","volume":"35","author":"Pichichero","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.11.046_b0050","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1016\/j.vaccine.2010.05.021","article-title":"Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: an analysis using the indirect cohort method","volume":"28","author":"Ruckinger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0055","first-page":"217","article-title":"Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines","volume":"16","author":"Lynch","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.vaccine.2016.11.046_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.coi.2011.04.002","article-title":"Next generation pneumococcal vaccines","volume":"23","author":"Moffitt","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tim.2009.12.001","article-title":"Potential role for mucosally active vaccines against pneumococcal pneumonia","volume":"18","author":"Jambo","year":"2010","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0070","doi-asserted-by":"crossref","first-page":"e39150","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.046_b0075","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.11.046_b0080","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1016\/j.vaccine.2012.10.080","article-title":"Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults","volume":"30","author":"Seiberling","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0085","doi-asserted-by":"crossref","first-page":"e78916","DOI":"10.1371\/journal.pone.0078916","article-title":"Vaccination against Streptococcus pneumoniae using truncated derivatives of polyhistidine triad protein D","volume":"8","author":"Plumptre","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.046_b0090","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1016\/j.vaccine.2012.10.076","article-title":"Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine","volume":"30","author":"Bologa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2012.11.005","article-title":"Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults","volume":"31","author":"Kamtchoua","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0100","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/IAI.06348-11","article-title":"Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury","volume":"80","author":"Salha","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.046_b0105","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.vaccine.2013.11.096","article-title":"Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children","volume":"32","author":"Xu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4161\/hv.19820","article-title":"Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children","volume":"8","author":"Pichichero","year":"2012","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.vaccine.2016.11.046_b0115","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/mi.2015.1","article-title":"Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children","volume":"8","author":"Xu","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0120","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.vaccine.2014.04.004","article-title":"Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model","volume":"32","author":"Verhoeven","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0125","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.vaccine.2015.01.014","article-title":"Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis","volume":"33","author":"Xu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.vaccine.2016.11.046_b0135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2010.09.019","article-title":"Nontypeable Streptococcus pneumoniae as an otopathogen","volume":"69","author":"Xu","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.046_b0140","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.ijporl.2011.07.026","article-title":"Tissue remodeling in the acute otitis media mouse model","volume":"75","author":"Sautter","year":"2011","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0145","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1128\/IAI.70.10.5589-5595.2002","article-title":"Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice","volume":"70","author":"Gor","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.046_b0150","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/IAI.73.3.1304-1312.2005","article-title":"Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae","volume":"73","author":"Gor","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.046_b0155","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/infdis\/jit502","article-title":"Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein","volume":"209","author":"Mann","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.046_b0160","doi-asserted-by":"crossref","unstructured":"Almudevar A, Pichichero ME. Modeling specific antibody responses to natural immunization to predict a correlate of protection against infection before commencing a clinical vaccine trial. Infectious Disease Week New Orleans, Louisiana. October 26\u201330; 2016.","DOI":"10.1093\/ofid\/ofw172.629"},{"key":"10.1016\/j.vaccine.2016.11.046_b0165","series-title":"Correlation of antibody levels to pneumococcal proteins with protection from acute otitis media but not nasopharyngeal colonization in young children","author":"Xu","year":"2016"},{"key":"10.1016\/j.vaccine.2016.11.046_b0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12865-015-0095-y","article-title":"Immunogenicity of infectious pathogens and vaccine antigens","volume":"16","author":"Mahanty","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0180","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/IAI.74.2.1171-1180.2006","article-title":"Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence","volume":"74","author":"Johnston","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.046_b0185","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/IAI.67.4.1943-1946.1999","article-title":"Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model","volume":"67","author":"Sato","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.046_b0190","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.4049\/jimmunol.180.6.4308","article-title":"Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways","volume":"180","author":"De Filippo","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0195","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1016\/j.vaccine.2015.06.078","article-title":"Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: a phase I randomized controlled study","volume":"33","author":"Brooks","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0200","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1080\/21645515.2015.1039210","article-title":"Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies","volume":"11","author":"Brookes","year":"2015","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2016.11.046_b0205","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/CVI.05443-11","article-title":"Antibody in middle ear fluid of children originates predominantly from sera and nasopharyngeal secretions","volume":"19","author":"Kaur","year":"2012","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2016.11.046_b0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/iai.7.4.589-593.1973","article-title":"Immunoglobulins of the middle ear fluid in acute otitis media: relationship to serum immunoglobulin concentrations and bacterial cultures","volume":"7","author":"Howie","year":"1973","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.046_b0215","article-title":"Protection against Streptococcus pneumoniae invasive pathogenesis by a protein based vaccine is achieved by suppression of nasopharyngeal bacterial density during Influenza A virus co-infection","author":"Khan","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2016.11.046_b0220","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.micinf.2012.06.007","article-title":"PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans","volume":"14","author":"Khan","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.11.046_b0225","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0230","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.4049\/jimmunol.1401413","article-title":"TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins","volume":"193","author":"Tomlinson","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.11.046_b0235","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/CS20150699","article-title":"Intranasal vaccination with gamma-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses","volume":"130","author":"Babb","year":"2016","journal-title":"Clin Sci"},{"key":"10.1016\/j.vaccine.2016.11.046_b0240","doi-asserted-by":"crossref","DOI":"10.1038\/pr.2016.154","article-title":"TLR2 promotes macrophage recruitment and Streptococcus pneumoniae clearance during mouse otitis media","author":"Huang","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2016.11.046_b0245","first-page":"611","article-title":"Mouse models of otitis media: strengths and limitations. Otolaryngology\u2013head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck","volume":"147","author":"Bhutta","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.vaccine.2016.11.046_b0250","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.vaccine.2008.01.029","article-title":"Mouse models for the study of mucosal vaccination against otitis media","volume":"26","author":"Sabirov","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.046_b0255","doi-asserted-by":"crossref","unstructured":"Melhus A, Ryan AF. A mouse model for acute otitis media, vol. 111. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica; 2003. p. 989\u201394.","DOI":"10.1034\/j.1600-0463.2003.1111012.x"},{"key":"10.1016\/j.vaccine.2016.11.046_b0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/317934","article-title":"Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B","volume":"183","author":"Saeland","year":"2001","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:32Z","timestamp":1759400612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16311082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0264410X16311082"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}